Shawn Rysling

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

University of California, Los Angeles(Current)

UCLA Medical Center

Harbor–UCLA Medical Center

Shawn Rysling is an author at University of California, Los Angeles specializing in mutation analysis, anti-inflammatory pharmacology, and fibrosis inhibition.

ORCID

Publications per year

2023–2024

Publications

Therapeutic effects of in vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study

Tsai‐Der Chuang, Nhu Ton, Shawn Rysling et al. · Fertility and Sterility · 2023 · 14 citations · Full text

Medicine, Biochemistry, Pharmacology +14

In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study

Tsai‐Der Chuang, Nhu Ton, Shawn Rysling et al. · Cells · 2024 · 11 citations · Full text

Medicine, Molecular Medicine, Oncology +13

The Influence of Race/Ethnicity on the Transcriptomic Landscape of Uterine Fibroids

Tsai‐Der Chuang, Nhu Ton, Shawn Rysling et al. · International Journal of Molecular Sciences · 2023 · 10 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

The Effect of Race/Ethnicity and MED12 Mutation on the Expression of Long Non-Coding RNAs in Uterine Leiomyoma and Myometrium

Tsai‐Der Chuang, Nhu Ton, Shawn Rysling et al. · International Journal of Molecular Sciences · 2024 · 10 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model

Tsai‐Der Chuang, Nhu Ton, Nathaly Manrique et al. · Clinical Science · 2024 · 10 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

1–5 of 5